A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer
M. Ghosn, P. Aftimos, F. S. Farhat, J. G. Kattan, C. Hanna, N. Haddad, F. Nasr, G. ChahineVolume:
28
Language:
english
Pages:
10
DOI:
10.1007/s12032-010-9754-2
Date:
December, 2011
File:
PDF, 447 KB
english, 2011